Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. AV was referred to the endocrinologist for ‘assessment and advice’ by her GP. Mrs. AV is a 68-year-old Greek-speaking woman with type 2 diabetes of 20 years’ duration. She has …
Read More »Diabetes In Control
Diagnosis and Management of Diabetic Neuropathies, Part 3 of 5
"On inspection the feet may look normal. There may be autonomic features of dry skin; distended veins that fail to collapse on raising the feet first described by my mentor Professor John Ward, There may be neuropathic oedema."
Read More »Editor’s Note: Whole Teams, Crushing Problems, and More Great Neuropathies Slides
We often talk of the “whole team” concept when treating our diabetes patients, and that usually includes a prescriber, a nurse, a diabetes educator and a pharmacist, but this week’s Case Discussion offers up the problems a 68-year-old Greek-speaking woman with type 2 diabetes of 20 years’ disease duration was …
Read More »Letter from the Editor: Flash Diet Successes and Interval Training
A couple of weeks ago I wrote about the “flash diet.” This program requires the participant to take a picture of everything that they are about to eat, usually with their phone camera, with the idea that they might not eat as much. I convinced three of my patients to …
Read More »FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator
FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Abbott has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime (bolus) insulin calculator for calculating suggested insulin doses. The system also offers a touch screen …
Read More »Annual Healthcare Costs Doubled in Under Nine Years
It has taken less than nine years for healthcare costs to double for the average family of four covered by a preferred provider organization. And there’s more bad news: employers are passing more of the costs on to their employees. The 2011 MMI healthcare cost is $19,393, a 7.3% or …
Read More »Insulin and Symlin Combo Studied
Scientists will mix insulin with Symlin to see if the combination injection works as well at controlling blood sugar levels as separately injected doses of the therapies. One of the biggest barriers to regular control of blood-sugar levels in diabetes patients is an inconsistent treatment regimen due in part to …
Read More »Acute Hyperglycemia Induces Endothelial Dysfunction
Type 2 diabetes is associated with many complications at the macro- and microvascular level. The impact of acute hyperglycemia on retinal as well as macrovascular circulation was investigated in a recent study. Vascular and endothelial function assessments included retinal vascular reactivity and flow-mediated dilatation of the brachial artery measured at …
Read More »“Fasting Pathway” Points the Way to New Class of Diabetes Drugs
A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.…
Read More »Fasting Plasma Glucose and Cardiometabolic Risk in Normoglycemic Children
In outpatient children and adolescents, higher FPG within the normal range is associated with several CMRF, independent of obesity.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.